[Preventing type 2 diabetes complications: from evidence-based recommendations to patient-based reality].
The vascular complications of type 2 diabetes count for the principal causes of morbidity, hospitalisation and mortality in this population. Therefore, preventing these complications is the cornerstone of the management of these patients. This prevention is through multifactorial interventions aiming at controlling the parameters of the metabolic syndrome in order to prevent or slow down these vascular complications. This prevention is also through a regular and exhaustive screening performed early enough in the disease. Above all, the management of these patients implies involving them as the main actors of their disease and treatments. This necessitates to take into account the beliefs and to actively seek the obstacles to therapeutic adherence.
Beer
S
S
Service d'endocrinologie, diabétologie et métabolisme, Département de médecine interne, CHUV, 1011 Lausanne. sandra.beer@chuv.hospvd.ch
Kunz
G Arnold
GA
Ruiz
J
J
D003266:Continuity of Patient Care; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D006801:Humans